We are pleased to announce the election of Dr. Todd E. Arnold to CURE’s Board of Directors.

Todd was recently named Chief Laboratory Operations Officer for Sema4, the spinout company of the Mount Sinai Health System formed by Mount Sinai and Eric Schadt.
Prior to his role at Sema4, Todd was the Managing Director of the Mount Sinai Genetic Testing Laboratory–Connecticut, a state of the art, high throughput nucleic acid sequencing facility.

Todd currently serves on the CURE Government Affairs Committee and has devoted special effort to the cultivation and retention of scientific and technical talent in Connecticut.